WS #10533
AbbVie is set to acquire Apogee Therapeutics in a $10.9 billion immunology deal, strengthening its pipeline.
AbbVie Acquires Apogee Therapeutics
AbbVie is set to acquire Apogee Therapeutics in a $10.9 billion immunology deal, strengthening its pipeline.